Gastroesophageal Reflux Disease (GERD) Therapeutics Market - Analysis By Drug Type, Region & Segment Forecasts to 2025 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Gastroesophageal Reflux Disease (GERD) Therapeutics Market 2014 - 2025" report to their offering.

The global Gastroesophageal Reflux Disease (GERD) therapeutics market is expected to reach USD 4.34 billion by 2025. The incidence of acid reflux disorder, also known as heartburn, is rapidly increasing worldwide. Various studies state that almost every person experiences acid reflux once in a lifetime.

The overall market has been experiencing a downturn in terms of revenue in the past several years as the leading drugs for GERD treatment have lost their patent protection, with their market shares now largely consumed by over-the-counter (OTC) and generic medications. Although loss of exclusivity of high-grossing drugs have caused a market fall-off, the demand for acid reducing drugs due to the high prevalence and incidence levels of GERD will prove beneficial to the industry from a commercial standpoint.

GERD is one of the commonly observed recurrent gastrointestinal disorders worldwide. The prevalence of acid reflux and related symptoms has increased across the globe by nearly 50% over the last decade. This disorder not only has major effects on the health and quality of patient lives, but also extends to the healthcare system and economy.

Companies Mentioned

  • Takeda Pharmaceutical Co., Ltd.
  • AstraZeneca PLC
  • Eisai Co., Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Daewoong Pharmaceutical Co., Ltd
  • Ironwood Pharmaceuticals, Inc.
  • RaQualia Pharma, Inc.
  • SFJ Pharmaceuticals Group
  • SRS Pharmaceuticals Pvt. Ltd
  • Reckitt Benckiser Group PLC
  • Novartis AG
  • Pfizer, Inc.
  • Abbott

Key Topics Covered:

1 Research Methodology & Scope

2 Executive Summary

3 GERD Therapeutics Market Variables, Trends & Scope

4 GERD Therapeutics Market: Drug Type Estimates & Trend Analysis

5 GERD Therapeutics Market: Regional Estimates & Trend Analysis

6 Competitive Landscape

For more information about this report visit http://www.researchandmarkets.com/research/bjrmhr/gastroesophageal

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Gastrointestinal Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Gastrointestinal Drugs